HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance.

Abstract
Mutations of Comparative Gene Identification-58 (CGI-58) in humans cause triglyceride (TG) accumulation in multiple tissues. Mice genetically lacking CGI-58 die shortly after birth due to a skin barrier defect. To study the role of CGI-58 in integrated lipid and energy metabolism, we utilized antisense oligonucleotides (ASOs) to inhibit CGI-58 expression in adult mice. Treatment with two distinct CGI-58-targeting ASOs resulted in ∼80-95% knockdown of CGI-58 protein expression in both liver and white adipose tissue. In chow-fed mice, ASO-mediated depletion of CGI-58 did not alter weight gain, plasma TG, or plasma glucose, yet raised hepatic TG levels ∼4-fold. When challenged with a high-fat diet (HFD), CGI-58 ASO-treated mice were protected against diet-induced obesity, but their hepatic contents of TG, diacylglycerols, and ceramides were all elevated, and intriguingly, their hepatic phosphatidylglycerol content was increased by 10-fold. These hepatic lipid alterations were associated with significant decreases in hepatic TG hydrolase activity, hepatic lipoprotein-TG secretion, and plasma concentrations of ketones, nonesterified fatty acids, and insulin. Additionally, HFD-fed CGI-58 ASO-treated mice were more glucose tolerant and insulin sensitive. Collectively, this work demonstrates that CGI-58 plays a critical role in limiting hepatic steatosis and maintaining hepatic glycerophospholipid homeostasis and has unmasked an unexpected role for CGI-58 in promoting HFD-induced obesity and insulin resistance.
AuthorsJ Mark Brown, Jenna L Betters, Caleb Lord, Yinyan Ma, Xianlin Han, Kui Yang, Heather M Alger, John Melchior, Janet Sawyer, Ramesh Shah, Martha D Wilson, Xiuli Liu, Mark J Graham, Richard Lee, Rosanne Crooke, Gerald I Shulman, Bingzhong Xue, Hang Shi, Liqing Yu
JournalJournal of lipid research (J Lipid Res) Vol. 51 Issue 11 Pg. 3306-15 (Nov 2010) ISSN: 1539-7262 [Electronic] United States
PMID20802159 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Dietary Fats
  • Oligonucleotides, Antisense
  • Phospholipids
  • Triglycerides
  • 1-Acylglycerol-3-Phosphate O-Acyltransferase
  • Abhd5 protein, mouse
Topics
  • 1-Acylglycerol-3-Phosphate O-Acyltransferase (deficiency, genetics)
  • Adipocytes, White (metabolism)
  • Animals
  • Diet (adverse effects)
  • Dietary Fats (adverse effects)
  • Fatty Liver (genetics, metabolism)
  • Gene Expression Regulation (genetics)
  • Gene Knockdown Techniques
  • Glucose Intolerance (etiology, genetics, prevention & control)
  • Insulin Resistance (genetics)
  • Liver (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Obesity (etiology, genetics, prevention & control)
  • Oligonucleotides, Antisense (genetics)
  • Phospholipids (metabolism)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: